NARA Discovery
Article Details
← Back to Search Results
Journal Article

ddPCR increases detection of SARS-CoV-2 RNA in patients with low viral loads

Agnès Marchio; Christophe Batejat; Jessica Vanhomwegen; Maxence Feher; Quentin Grassin; Maxime Chazal; Olivia Raulin; Anne Farges-Berth; Florence Reibel; Vincent Estève; Anne Dejean; Nolwenn Jouvenet; Jean-Claude Manuguerra; Pascal Pineau
Archives of Virology · Vol. 166, Issue 9 · pp. 2529-2540 · 2021

Abstract

RT-qPCR detection of SARS-CoV-2 RNA still represents the method of reference to diagnose and monitor COVID-19. From the onset of the pandemic, however, doubts have been expressed concerning the sensitivity of this molecular diagnosis method. Droplet digital PCR (ddPCR) is a third-generation PCR technique that is particularly adapted to detecting low-abundance targets. We developed two-color ddPCR assays for the detection of four different regions of SARS-CoV-2 RNA, including non-structural (IP4-RdRP, helicase) and structural (E, N) protein-encoding sequences. We observed that N or E subgenomic RNAs are generally more abundant than IP4 and helicase RNA sequences in cells infected in vitro , suggesting that detection of the N gene, coding for the most abundant subgenomic RNA of SARS-CoV-2, increases the sensitivity of detection during the highly replicative phase of infection. We investigated 208 nasopharyngeal swabs sampled in March-April 2020 in different hospitals of Greater Paris. We found that 8.6% of informative samples (n = 16/185, P

Bibliographic Information

JournalArchives of Virology
PublisherSpringer
Publication Date2021-09-01
Publication Year2021
Volume166
Issue9
Pages2529-2540
Document TypeJournal Article
Print ISSN0304-8608
eISSN1432-8798
DOI10.1007/s00705-021-05149-0

Access Information

NARA Access Coverage1939-01-01~Current
Journal Homepagehttps://www.springer.com/journal/705
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.